David Halverson - Protea Biosciences Vice President Chief Business Officer
President
Mr. David Halverson is President, Chief Business Officer of the Company. From 2006 to 2011 he served in several positions with Huntingdon.Life Sciences including Head of European and U.S. sales. From 2001 to 2006 he served as a Director of Sales for PPD Discovery and Quintiles Preclinical Groups. From 1993 to 2001 he served as a Staff Scientist in the Drug Metabolism Group at Covance Laboratories. He graduated from Kemper Military Academy in 1987 and received a commission as 2LT in the US Army and served on active duty, Wisconsin National Guard, and Army Reserve through 2000 since 2016.
| Age | 50 |
| Tenure | 8 years |
| Phone | 304-292-2226 |
| Web | http://www.proteabio.com |
Protea Biosciences Management Efficiency
The company has return on total asset (ROA) of (104.33) % which means that it has lost $104.33 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (31.9) %, meaning that it created substantial loss on money invested by shareholders. Protea Biosciences' management efficiency ratios could be used to measure how well Protea Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 10.93 M in liabilities. Protea Biosciences has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Protea Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Protea Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Protea Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Protea to invest in growth at high rates of return. When we think about Protea Biosciences' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Frank Baron | The Hanover Insurance | N/A | |
| Andrew Robinson | The Hanover Insurance | 49 | |
| Anil Hinduja | Federal Home Loan | 54 | |
| Timothy Kitt | Federal Home Loan | N/A | |
| Mark Welzenbach | The Hanover Insurance | 61 | |
| Carol Wambeke | Federal Home Loan | 54 | |
| Robert Lux | Federal Home Loan | 52 | |
| Deborah Jenkins | Federal Home Loan | 50 | |
| Mark DeLong | Federal Home Loan | 60 | |
| Jeff Walsh | Loandepot | 60 | |
| Mina Rona | The Hanover Insurance | N/A | |
| Ann Tripp | The Hanover Insurance | 61 | |
| Eli Baker | Willscot Mobile Mini | 39 | |
| Willard Lee | The Hanover Insurance | 54 | |
| Mark Keim | The Hanover Insurance | 50 | |
| Richard Lavey | The Hanover Insurance | 56 | |
| Kathleen DeCastro | The Hanover Insurance | 46 | |
| Jorge Reis | Federal Home Loan | 49 | |
| Hezron Lopez | Willscot Mobile Mini | 53 | |
| Stacey Goodman | Federal Home Loan | 55 | |
| Bryan Salvatore | The Hanover Insurance | 59 | |
Management Performance
| Return On Equity | -31.9 | |||
| Return On Asset | -104.33 |
Protea Biosciences Leadership Team
Elected by the shareholders, the Protea Biosciences' board of directors comprises two types of representatives: Protea Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Protea. The board's role is to monitor Protea Biosciences' management team and ensure that shareholders' interests are well served. Protea Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Protea Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Leonard Harris, Independent Director | ||
| Stephen Turner, Chairman, CEO and Pres | ||
| Gregory Kilby, COO and VP of Operations | ||
| Edwin Roberson, Independent Director | ||
| Stanley Hostler, VP, Secretary, Director and Member of Audit Committee | ||
| Steven Antoline, Independent Director | ||
| Edward Hughes, CFO | ||
| Scott Segal, Independent Director | ||
| Ed Roberson, Independent Director | ||
| Patrick Gallagher, Director | ||
| Andrew Zulauf, Independent Director | ||
| Josiah Austin, Independent Director | ||
| Matthew Powell, Chief Science Officer and VP of RandD | ||
| David Halverson, Vice President Chief Business Officer | ||
| Maged Shenouda, Director |
Protea Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Protea Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -31.9 | |||
| Return On Asset | -104.33 | |||
| Operating Margin | (261.55) % | |||
| Current Valuation | 11.29 M | |||
| Shares Outstanding | 8.03 M | |||
| Shares Owned By Insiders | 49.85 % | |||
| Shares Owned By Institutions | 0.07 % | |||
| Price To Earning | (0.23) X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 2.07 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Protea Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Protea Biosciences' short interest history, or implied volatility extrapolated from Protea Biosciences options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Protea Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Protea Biosciences information on this page should be used as a complementary analysis to other Protea Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Protea OTC BB Equity
If you are still planning to invest in Protea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Protea Biosciences' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |